17β-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion

Circulation

Volumn 94, Issue 11, 1996, Pages 2901-2908

  Kim, Young D ^a   Chen, Barbara ^a   Beauregard, John ^a   Kouretas, Peter ^a   Thomas, George ^a   Farhat, Michel Y ^a   Myers, Adam K ^a   Lees, David E ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

endothelium; hormones; ischemia; reperfusion

Indexed keywords

ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ESTROGEN THERAPY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HYPERCHOLESTEROLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY;

EID: 0029800182     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2901     Document Type: Article

References (48)

1. Hearse DJ, Myocardial injury during ischemia and reperfusion: concept and controversies. In: Yellon DM, Jennings RB, eds. Myocardial Protection: The Physiology of Reperfusion and Reperfusion Injury, New York, NY: Raven Press: 1992:13-33.
2. Bolli R, Fisher DJ, Entman ML. Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. Am Heart J. 1986;111:261-270.
3. Kim YD, Fomsgaard JS, Heim KF, Ramwell PW, Thomas G, Kagan E, Moore SP, Coughlin SS, Kuwahara M, Analouei A. Brief ischemia-reperfusion induces stunning of endothelium in the canine coronary artery. Circulation. 1992;85:1473-1482.
4. Bolli R, Triana JF, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischemia: evidence for microvascular 'stunning.' Circ Res. 1990;67:332-343.
5. Mullane KM, Young M. The contribution of neutrophil activation and changes in endothelial function to myocardial ischemia-reperfusion injury. In: Yellon DM, Jennings RB, eds. Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury. New York, NY: Raven Press: 1992:59-83.
6. McCord JM. Oxygen free radicals in post ischemic tissue injury. N Engl J Med. 1985;312:159-163.
7. Lefer AM, Lefer DJ, Pharmacology of the endothelium in ischemia/reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 1993;33:71-90.
8. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
9. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Spelzer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. N Engl J Med. 1991;325:756-762.
10. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
11. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem. 1988;34(8B):B60-B70.
12. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
13. Keaney JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
14. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function on postmenopausal women. Circulation. 1994;89:2545-2551.
15. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not in men with coronary artery disease. Circulation. 1995;92:24-30.
16. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate: a two year follow-up study. Hypertension. 1995;25:848-853.
17. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994;94:5212-5216.
18. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 1993;45:509-511.
19. Maziere C, Auclair M, Ronveaux MF, Salmon S, Santus R, Maziere JC. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 1991;89:175-182.
20. Sugioka K, Shimosegawa Y, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1987;210:37-39.
21. Simon BC, Cunningham LD, Cohen RA. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
22. Weitz ZW, Birnbaum AJ, Subotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during acute myocardial infarction. Lancet. 1991;337:933-935.
23. Heim KF, Makila UM, Leveson P, Ledley GS, Thomas G, Rackley C, Ramwell PW. Detection of pentane as a measurement of lipid peroxidation in humans using gas chromatography with a photoionization detector. In: Paubert-Braguet M, ed. Lipid Mediators in the Immunology of Shock. New York, NY: Plenum Publishing Co; 1987:103-108.
24. Kohlmüller D, Kochen W. Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Anal Biochem. 1993;210:268-276.
25. Jurjen H, Pratt JJ, Woldring MG. Radioimmunoassay of plasma estradiol without extraction and chromatography. J Clin Endocrinol Metab. 1975;40:19-25.
26. Theraux P, Franklin D, Ross J Jr, Kemper WS. Regional myocardial function during acute coronary artery occlusion and its modification by pharmacological agents in the dog. Circ Res. 1974;35:896-908.
27. Walker MJ, Curtis MJ, Hearse DJ, Campbell WF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Reimersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion. Cardiovasc Res. 1988;22:447-455.
28. Kowallik P, Schulz R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G. Measurement of regional myocardial bloodflow with multiple colored microspheres. Circulation. 1991;83:974-982.
29. Bolli R, Zhu WX, Thornby JI, O'Neill PC, Roberts R. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 1988;254:H102-H114.
30. Takashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurement of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation of atherosclerosis. J Cardiovasc Pharmacol. 1992;20:S214-S216.
31. Wang JF, Komarov P, Sies H, DeGroot H. Inhibition of Superoxide and nitric oxide release and protection from reoxygenation injury by Ebselen in rat Kupffer cells. Hepatology. 1992;15:1112-1116.
32. - secreted by monocytes and macrophages. Methods Enzymol. 1984;105:365-370.
33. Zughaib ME, Tang XL, Sun JZ, Bolli R. Myocardial reperfusion injury: fact or myth? A 1993 appraisal of a seemingly endless controversy. Ann N Y Acad Sci. 1994;723:218-228.
34. Fox KA. Reperfusion injury: a clinical perspective. In: Yellon DM, Jennings RB, eds. Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury. New York, NY: Raven Press; 1992:151-163.
35. Jeroudi MO, Hentley CJ, Bolli R. Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol. 1994;73:2B-7B.
36. McHugh NA, Cooks M, Schairer JL, Bidgoli MM, Merrill GF. Ischemia and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol. 1995;268:H2569-H2573.
37. VanBenthuysen KM, McMurtey IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcnoline and augments contractile reactivity in vitro. J Clin Invest. 1987;79:265-274.
38. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tertbutyl nitrone. J Clin Invest. 1988;82:476-485.
39. Rubanyi GM. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med. 1988;4:107-120.
40. Hale SL, Birnbaum Y, Kloner RA. 17β-Estradiol protects ischemic myocardium after occlusion and reperfusion in the rabbit. Presented at the American Heart Association Scientific Conference on Hormonal, Metabolic, and Cellular Influences on Cardiovascular Disease in Women; October 19-21, 1995; San Diego, Calif.
41. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992;20:452-457.
42. Williams JK, Adams MR, Klopfenstein HB. Estrogen modulates responses to atherosclerotic coronary arteries. Circulation. 1995;81:1680-1687.
43. Gerland M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation. 1995;92:5-8.
44. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343:269-270.
45. Oberley TD, Schultz JL, Oberley LW. In vitro modulation of antioxidant enzyme levels in normal hamster kidney and estrogen-induced hamster kidney tumor. Free Radic Biol Med. 1994;16:741-747.
46. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O. 17β-Estradiol stimulates prostacyclin but not endothelin-1 production in human vascular smooth muscle cells. J Clin Endocrinol Metab. 1995;80:1832-1836.
47. Halliwell B, Grootveld M. The measurement of free radical reactions in humans: some thoughts for future experimentation. FEBS Lett. 1987;213:9-14.
48. O'Connell MB. Pharmacokinetics and pharmacologic variation between different estrogen products. J Clin Pharmacol. 1995;35:185-245.